Skip to main content
Top
Published in: Diagnostic Pathology 1/2014

Open Access 01-12-2014 | Research

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan

Authors: Atif Ali Hashmi, Muhammad Muzzammil Edhi, Hanna Naqvi, Naveen Faridi, Amna Khurshid, Mehmood Khan

Published in: Diagnostic Pathology | Issue 1/2014

Login to get access

Abstract

Background

Young age breast cancers are quite prevalent in our setup, a significant number of which exhibit triple negative phenotype. These cancers behave in an aggressive fashion and unresponsive to targeted adjuvant therapy. We aimed to evaluate clinical and histopathologic features of triple negative cancers in our population.

Methods

We retrospectively evaluated 1104 cases of primary breast cancers. Immunohistochemical studies for ER, PR and Her2neu followed by Her2neu gene amplification by FISH testing were done to identify 205 (18.6%) cases of triple negative breast cancers.

Results

Mean age for triple negative breast cancer patients was 48.4 years (±12.3) and 60% of patients were diagnosed at less than 50 years of age. Although ductal carcinoma was the most frequent histologic type, a meaningful number of cases exhibited metaplastic and medullary like features (10.7% and 5.9% respectively). Similarly geographic necrosis involving more than 40% of tumor and extensive lymphocytic infiltration was a considerable finding. Mean Ki67 index was 45.2% (±25.2) and as a reflection of tumor grade, a significantly higher proportion of cases (66.3%) were under high risk Ki67 category (>30%).

Conclusion

Triple negative breast cancers typify high grade breast cancers with a higher frequency of atypical medullary and metaplastic histologies. Their prevailing occurrence at a younger age raises question of under lying BRCA mutations in our population. Therefore, we suggest that risk factors including BRCA 1 mutations should be uncovered in reproductive age group breast cancers especially those disclosing basal like phenotype.

Virtual slides

The virtual slide(s) for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​9042440621102239​.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001, 98: 10869-10874. 10.1073/pnas.191367098.PubMedPubMedCentralCrossRef Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001, 98: 10869-10874. 10.1073/pnas.191367098.PubMedPubMedCentralCrossRef
2.
go back to reference Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS: Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009, 27: 1160-1167. 10.1200/JCO.2008.18.1370. doi:10.1200/JCO.2008.18.1370PubMedPubMedCentralCrossRef Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS: Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009, 27: 1160-1167. 10.1200/JCO.2008.18.1370. doi:10.1200/JCO.2008.18.1370PubMedPubMedCentralCrossRef
3.
go back to reference Moldovan L, Mitroi A, Petrescu CM, Aschie M: Classification of breast carcinomas according to gene expression profiles. J Med Life. 2013, 6 (1): 14-17.PubMedPubMedCentral Moldovan L, Mitroi A, Petrescu CM, Aschie M: Classification of breast carcinomas according to gene expression profiles. J Med Life. 2013, 6 (1): 14-17.PubMedPubMedCentral
4.
go back to reference Brenton JD, Carey LA, Ahmed AA, Caldas C: Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol. 2005, 23: 7350-7360. 10.1200/JCO.2005.03.3845.PubMedCrossRef Brenton JD, Carey LA, Ahmed AA, Caldas C: Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol. 2005, 23: 7350-7360. 10.1200/JCO.2005.03.3845.PubMedCrossRef
5.
go back to reference Alshareeda AT, Soria D, Garibaldi JM, Rakha E, Nolan C, Ellis IO, Green AR: Characteristics of basal cytokeratin expression in breast cancer. Breast Cancer Res Treat. 2013, 139 (1): 23-37. 10.1007/s10549-013-2518-x.PubMedCrossRef Alshareeda AT, Soria D, Garibaldi JM, Rakha E, Nolan C, Ellis IO, Green AR: Characteristics of basal cytokeratin expression in breast cancer. Breast Cancer Res Treat. 2013, 139 (1): 23-37. 10.1007/s10549-013-2518-x.PubMedCrossRef
6.
go back to reference Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007, 131 (1): 18-43.PubMed Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007, 131 (1): 18-43.PubMed
7.
go back to reference Bhurgri Y, Bhurgri A, Nishter S, Ahmed A, Usman A, Pervez S, Ahmed R, Kayani N, Riaz A, Bhurgri H, Bashir I, Hassan SH: Pakistan-Country profile of cancer and cancer control 1995-2004. J Pak Med Assoc. 2006, 56 (3): 124-130.PubMed Bhurgri Y, Bhurgri A, Nishter S, Ahmed A, Usman A, Pervez S, Ahmed R, Kayani N, Riaz A, Bhurgri H, Bashir I, Hassan SH: Pakistan-Country profile of cancer and cancer control 1995-2004. J Pak Med Assoc. 2006, 56 (3): 124-130.PubMed
8.
go back to reference Bhurgri Y, Bhurgri A, Hassan SH, Zaidi SHM, Rahim A, Sankaranarayanan R, Parkin DM: Cancer incidence in Karachi, Pakistan: first results from Karachi cancer registry. Int J Cancer. 2000, 85: 325-329. 10.1002/(SICI)1097-0215(20000201)85:3<325::AID-IJC5>3.0.CO;2-J.PubMedCrossRef Bhurgri Y, Bhurgri A, Hassan SH, Zaidi SHM, Rahim A, Sankaranarayanan R, Parkin DM: Cancer incidence in Karachi, Pakistan: first results from Karachi cancer registry. Int J Cancer. 2000, 85: 325-329. 10.1002/(SICI)1097-0215(20000201)85:3<325::AID-IJC5>3.0.CO;2-J.PubMedCrossRef
9.
go back to reference Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s surveillance, epidemiology, and end results database. Cancer. 2007, 110: 876-10.1002/cncr.22836.PubMedCrossRef Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s surveillance, epidemiology, and end results database. Cancer. 2007, 110: 876-10.1002/cncr.22836.PubMedCrossRef
10.
go back to reference Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE: Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.–aSEER analysis. BMC Cancer. 2010, 10: 191-10.1186/1471-2407-10-191.PubMedPubMedCentralCrossRef Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE: Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.–aSEER analysis. BMC Cancer. 2010, 10: 191-10.1186/1471-2407-10-191.PubMedPubMedCentralCrossRef
11.
go back to reference Cheng HT, Huang T, Wang W, Yue JQ, Shen N, Guo H, Li DP, Zhao QZ, Yi PF, Wang R, Wang LQ: Clinicopathological features of breast cancer with different molecular subtypes in Chinese women. J Huazhong Univ Sci Technolog Med Sci. 2013, 33 (1): 117-121. 10.1007/s11596-013-1082-2.PubMedCrossRef Cheng HT, Huang T, Wang W, Yue JQ, Shen N, Guo H, Li DP, Zhao QZ, Yi PF, Wang R, Wang LQ: Clinicopathological features of breast cancer with different molecular subtypes in Chinese women. J Huazhong Univ Sci Technolog Med Sci. 2013, 33 (1): 117-121. 10.1007/s11596-013-1082-2.PubMedCrossRef
12.
go back to reference Bhurgri Y, Kayani N, Faridi N, Pervez S, Usman A, Bhurgri H, Malik J, Bashir I, Bhurgri A, Hasan SH, Zaidi SH: Patho-epidemiology of breast cancer in Karachi “1995-1997”. Asian Pac J Cancer Prev. 2007, 8 (2): 215-220.PubMed Bhurgri Y, Kayani N, Faridi N, Pervez S, Usman A, Bhurgri H, Malik J, Bashir I, Bhurgri A, Hasan SH, Zaidi SH: Patho-epidemiology of breast cancer in Karachi “1995-1997”. Asian Pac J Cancer Prev. 2007, 8 (2): 215-220.PubMed
13.
go back to reference Hashmi AA, Faridi N, Khurshid A, Naqvi H, Malik B, Malik FR, Fida Z, Mujtuba S: Accuracy of frozen section analysis of sentinel lymph nodes for the detection of Asian breast cancer micrometastasis–experience from Pakistan. Asian Pac J Cancer Prev. 2013, 14 (4): 2657-2662. 10.7314/APJCP.2013.14.4.2657.PubMedCrossRef Hashmi AA, Faridi N, Khurshid A, Naqvi H, Malik B, Malik FR, Fida Z, Mujtuba S: Accuracy of frozen section analysis of sentinel lymph nodes for the detection of Asian breast cancer micrometastasis–experience from Pakistan. Asian Pac J Cancer Prev. 2013, 14 (4): 2657-2662. 10.7314/APJCP.2013.14.4.2657.PubMedCrossRef
14.
go back to reference Collins LC, Botero ML, Schnitt SJ: Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer. Am J Clin Pathol. 2005, 123: 16-20. 10.1309/HCF035N9WK40ETJ0.PubMedCrossRef Collins LC, Botero ML, Schnitt SJ: Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer. Am J Clin Pathol. 2005, 123: 16-20. 10.1309/HCF035N9WK40ETJ0.PubMedCrossRef
15.
go back to reference Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25 (1): 118-145.PubMedCrossRef Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25 (1): 118-145.PubMedCrossRef
16.
go back to reference Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007, 18: 1133-1144. 10.1093/annonc/mdm271.PubMedCrossRef Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007, 18: 1133-1144. 10.1093/annonc/mdm271.PubMedCrossRef
17.
go back to reference Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ: Thresholds for therapies: highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009, 20: 1319-1329. 10.1093/annonc/mdp322.PubMedPubMedCentralCrossRef Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ: Thresholds for therapies: highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009, 20: 1319-1329. 10.1093/annonc/mdp322.PubMedPubMedCentralCrossRef
18.
go back to reference Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, Eley JW: The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control. 2009, 20: 1071-10.1007/s10552-009-9331-1. doi: 10.1007/s10552-009-9331-1PubMedCrossRef Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, Eley JW: The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control. 2009, 20: 1071-10.1007/s10552-009-9331-1. doi: 10.1007/s10552-009-9331-1PubMedCrossRef
19.
go back to reference Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI: Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011, 103: 470-10.1093/jnci/djr030. doi: 10.1093/jnci/djr030PubMedPubMedCentralCrossRef Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI: Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011, 103: 470-10.1093/jnci/djr030. doi: 10.1093/jnci/djr030PubMedPubMedCentralCrossRef
20.
go back to reference Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008, 109: 123-10.1007/s10549-007-9632-6.PubMedPubMedCentralCrossRef Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008, 109: 123-10.1007/s10549-007-9632-6.PubMedPubMedCentralCrossRef
21.
go back to reference Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H: Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest. 2002, 82: 1525-10.1097/01.LAB.0000038508.86221.B3.PubMedCrossRef Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H: Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest. 2002, 82: 1525-10.1097/01.LAB.0000038508.86221.B3.PubMedCrossRef
22.
go back to reference Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, van Diest PJ, Brandt B, Boecker W, Buerger H: How basal are triple-negative breast cancers?. Int J Cancer. 2008, 123: 236-10.1002/ijc.23518. doi:10.1002/ijc.23518PubMedCrossRef Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, van Diest PJ, Brandt B, Boecker W, Buerger H: How basal are triple-negative breast cancers?. Int J Cancer. 2008, 123: 236-10.1002/ijc.23518. doi:10.1002/ijc.23518PubMedCrossRef
23.
go back to reference Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011, 121: 2750-10.1172/JCI45014. doi:10.1172/JCI45014PubMedPubMedCentralCrossRef Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011, 121: 2750-10.1172/JCI45014. doi:10.1172/JCI45014PubMedPubMedCentralCrossRef
24.
go back to reference Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C: An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007, 8: R157-10.1186/gb-2007-8-8-r157.PubMedPubMedCentralCrossRef Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C: An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007, 8: R157-10.1186/gb-2007-8-8-r157.PubMedPubMedCentralCrossRef
25.
go back to reference Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010, 12: R68-10.1186/bcr2635. doi: 10.1186/bcr2635PubMedPubMedCentralCrossRef Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010, 12: R68-10.1186/bcr2635. doi: 10.1186/bcr2635PubMedPubMedCentralCrossRef
26.
go back to reference Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ: Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res. 2007, 9 (5): R65-10.1186/bcr1771.PubMedPubMedCentralCrossRef Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ: Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res. 2007, 9 (5): R65-10.1186/bcr1771.PubMedPubMedCentralCrossRef
27.
go back to reference Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A: Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. 2006, 49 (1): 22-34. 10.1111/j.1365-2559.2006.02453.x.PubMedCrossRef Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A: Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. 2006, 49 (1): 22-34. 10.1111/j.1365-2559.2006.02453.x.PubMedCrossRef
28.
go back to reference Carter MR, Hornick JL, Lester S, Fletcher CD: Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006, 30: 300-309.PubMed Carter MR, Hornick JL, Lester S, Fletcher CD: Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006, 30: 300-309.PubMed
29.
go back to reference Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast: IV: squamous cell carcinoma of ductal origin. Cancer. 1990, 65: 272-276. 10.1002/1097-0142(19900115)65:2<272::AID-CNCR2820650215>3.0.CO;2-6.PubMedCrossRef Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast: IV: squamous cell carcinoma of ductal origin. Cancer. 1990, 65: 272-276. 10.1002/1097-0142(19900115)65:2<272::AID-CNCR2820650215>3.0.CO;2-6.PubMedCrossRef
30.
go back to reference Rosen PP, Ernsberger D: Low-grade adenosquamous carcinoma: a variant of metaplastic mammary carcinoma. Am J Surg Pathol. 1987, 11: 351-358. 10.1097/00000478-198705000-00003.PubMedCrossRef Rosen PP, Ernsberger D: Low-grade adenosquamous carcinoma: a variant of metaplastic mammary carcinoma. Am J Surg Pathol. 1987, 11: 351-358. 10.1097/00000478-198705000-00003.PubMedCrossRef
31.
go back to reference Hanna W, Kahn HJ: Ultrastructural and immunohistochemical characteristics of mucoepidermoid carcinoma of the breast. Hum Pathol. 1985, 16: 941-946. 10.1016/S0046-8177(85)80133-7.PubMedCrossRef Hanna W, Kahn HJ: Ultrastructural and immunohistochemical characteristics of mucoepidermoid carcinoma of the breast. Hum Pathol. 1985, 16: 941-946. 10.1016/S0046-8177(85)80133-7.PubMedCrossRef
32.
go back to reference Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast: V: metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 1990, 21: 1142-1150. 10.1016/0046-8177(90)90151-T.PubMedCrossRef Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast: V: metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 1990, 21: 1142-1150. 10.1016/0046-8177(90)90151-T.PubMedCrossRef
33.
go back to reference Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A: Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol. 2001, 25: 1009-1016. 10.1097/00000478-200108000-00004.PubMedCrossRef Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A: Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol. 2001, 25: 1009-1016. 10.1097/00000478-200108000-00004.PubMedCrossRef
34.
go back to reference Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC: Metaplastic breast carcinomas are basal-like tumours. Histopathology. 2006, 49: 10-21. 10.1111/j.1365-2559.2006.02467.x.PubMedCrossRef Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC: Metaplastic breast carcinomas are basal-like tumours. Histopathology. 2006, 49: 10-21. 10.1111/j.1365-2559.2006.02467.x.PubMedCrossRef
35.
go back to reference Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, Debono S, Houvenaeghel G, Maraninchi D, Viens P, Charpin C, Jacquemier J, Birnbaum D: Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006, 66: 4636-4644. 10.1158/0008-5472.CAN-06-0031.PubMedCrossRef Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, Debono S, Houvenaeghel G, Maraninchi D, Viens P, Charpin C, Jacquemier J, Birnbaum D: Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006, 66: 4636-4644. 10.1158/0008-5472.CAN-06-0031.PubMedCrossRef
36.
go back to reference Royston P, Altman DG, Sauerbrei W: Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006, 25: 127-141. 10.1002/sim.2331.PubMedCrossRef Royston P, Altman DG, Sauerbrei W: Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006, 25: 127-141. 10.1002/sim.2331.PubMedCrossRef
37.
go back to reference Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Gusterson BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS: Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst. 2008, 100: 207-212. 10.1093/jnci/djm289.PubMedCrossRef Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Gusterson BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS: Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst. 2008, 100: 207-212. 10.1093/jnci/djm289.PubMedCrossRef
38.
go back to reference Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A: Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol. 2009, 20 (4): 628-635. 10.1093/annonc/mdn675.PubMedCrossRef Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A: Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol. 2009, 20 (4): 628-635. 10.1093/annonc/mdn675.PubMedCrossRef
39.
go back to reference Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO: Expression profiling technology: its contribution to our understanding of breast cancer. Histopathology. 2008, 52: 67-81. doi:10.1111/j.1365-2559.2007.02894.xPubMedCrossRef Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO: Expression profiling technology: its contribution to our understanding of breast cancer. Histopathology. 2008, 52: 67-81. doi:10.1111/j.1365-2559.2007.02894.xPubMedCrossRef
40.
go back to reference Sotiriou C, Pusztai L: Gene-expression signatures in breast cancer. N Engl J Med. 2009, 360: 790-800. 10.1056/NEJMra0801289.PubMedCrossRef Sotiriou C, Pusztai L: Gene-expression signatures in breast cancer. N Engl J Med. 2009, 360: 790-800. 10.1056/NEJMra0801289.PubMedCrossRef
41.
go back to reference Vallejos CS, Gómez HL, Cruz WR, Pinto JA, Dyer RR, Velarde R, Suazo JF, Neciosup SP, León M, de la Cruz MA, Vigil CE: Breast cancer classification according to immunohistochemistry markers: subtypes and association withclinicopathologic variables in a peruvian hospital database. Clin Breast Cancer. 2010, 10 (4): 294-300. 10.3816/CBC.2010.n.038.PubMedCrossRef Vallejos CS, Gómez HL, Cruz WR, Pinto JA, Dyer RR, Velarde R, Suazo JF, Neciosup SP, León M, de la Cruz MA, Vigil CE: Breast cancer classification according to immunohistochemistry markers: subtypes and association withclinicopathologic variables in a peruvian hospital database. Clin Breast Cancer. 2010, 10 (4): 294-300. 10.3816/CBC.2010.n.038.PubMedCrossRef
42.
go back to reference Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, et al.: Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010, 25: 7(5)- Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, et al.: Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010, 25: 7(5)-
43.
go back to reference Cakir A, Gonul II, Uluoglu O: A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-likecarcinomas. Diagn Pathol. 2012, 7: 145-10.1186/1746-1596-7-145.PubMedPubMedCentralCrossRef Cakir A, Gonul II, Uluoglu O: A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-likecarcinomas. Diagn Pathol. 2012, 7: 145-10.1186/1746-1596-7-145.PubMedPubMedCentralCrossRef
44.
go back to reference Cheng H, Qin Y, Fan H, Su P, Zhang X, Zhang H, Zhou G: Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol. 2013, 8: 129-10.1186/1746-1596-8-129.PubMedPubMedCentralCrossRef Cheng H, Qin Y, Fan H, Su P, Zhang X, Zhang H, Zhou G: Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol. 2013, 8: 129-10.1186/1746-1596-8-129.PubMedPubMedCentralCrossRef
45.
go back to reference Klingen TA, Chen Y, Suhrke P, Stefansson IM, Gundersen MD, Akslen LA: Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. Diagn Pathol. 2013, 8: 80-10.1186/1746-1596-8-80.PubMedPubMedCentralCrossRef Klingen TA, Chen Y, Suhrke P, Stefansson IM, Gundersen MD, Akslen LA: Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. Diagn Pathol. 2013, 8: 80-10.1186/1746-1596-8-80.PubMedPubMedCentralCrossRef
46.
go back to reference Liu L, Liu Z, Qu S, Zheng Z, Liu Y, Xie X, Song F: Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients. Diagn Pathol. 2013, 8: 71-10.1186/1746-1596-8-71.PubMedPubMedCentralCrossRef Liu L, Liu Z, Qu S, Zheng Z, Liu Y, Xie X, Song F: Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients. Diagn Pathol. 2013, 8: 71-10.1186/1746-1596-8-71.PubMedPubMedCentralCrossRef
47.
go back to reference Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R: MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagn Pathol. 2012, 7: 31-10.1186/1746-1596-7-31.PubMedPubMedCentralCrossRef Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R: MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagn Pathol. 2012, 7: 31-10.1186/1746-1596-7-31.PubMedPubMedCentralCrossRef
48.
go back to reference Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J: Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol. 2012, 7: 27-10.1186/1746-1596-7-27.PubMedPubMedCentralCrossRef Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J: Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol. 2012, 7: 27-10.1186/1746-1596-7-27.PubMedPubMedCentralCrossRef
49.
go back to reference Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 2006, 295 (21): 2492-2502. 10.1001/jama.295.21.2492.PubMedCrossRef Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 2006, 295 (21): 2492-2502. 10.1001/jama.295.21.2492.PubMedCrossRef
50.
go back to reference Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007, 109 (9): 1721-1728. 10.1002/cncr.22618.PubMedCrossRef Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007, 109 (9): 1721-1728. 10.1002/cncr.22618.PubMedCrossRef
51.
go back to reference Giles GG, English DR: The Melbourne collaborative cohort study. IARC Sci Publ. 2002, 156: 69-70.PubMed Giles GG, English DR: The Melbourne collaborative cohort study. IARC Sci Publ. 2002, 156: 69-70.PubMed
52.
go back to reference Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA: The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res. 2004, 64: 830-10.1158/0008-5472.CAN-03-2970.PubMedCrossRef Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA: The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res. 2004, 64: 830-10.1158/0008-5472.CAN-03-2970.PubMedCrossRef
53.
go back to reference Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003, 95: 1482-10.1093/jnci/djg050.PubMedCrossRef Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003, 95: 1482-10.1093/jnci/djg050.PubMedCrossRef
54.
go back to reference Olopade OI, Grushko T: Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001, 344: 2028-PubMedCrossRef Olopade OI, Grushko T: Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001, 344: 2028-PubMedCrossRef
Metadata
Title
Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
Authors
Atif Ali Hashmi
Muhammad Muzzammil Edhi
Hanna Naqvi
Naveen Faridi
Amna Khurshid
Mehmood Khan
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2014
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-9-43

Other articles of this Issue 1/2014

Diagnostic Pathology 1/2014 Go to the issue